|
Rosuvastatin Clinical Trials
4 actively recruiting trials across 3 locations
▲ +1 trial since August 2026
Also known as: Rosuvastatin 10 mg, Rosuvastatin 20 mg
Pipeline
Phase 1: 1Phase 2: 1Phase 4: 2
Top Sponsors
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
- Nanjing First Hospital, Nanjing Medical University1
- Eli Lilly and Company1
- Brigham and Women's Hospital1
Indications
- Cancer2
- Cirrhosis Alcoholic1
- Cirrhosis Infectious1
- Cirrhosis Advanced1
- Cirrhosis Early1
Other1 trial
Tucson, Arizona1 trial
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
University of Arizona - Cancer Center
Phase 1
Irvine, California1 trial
Statins to Prevent Cancer Associated Blood Clots
City of Hope
Phase 4
La Jolla, California1 trial
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
University of California San Diego NAFLD Research Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.